LXEO Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Advances NATR Q1 2026 Earnings Strong EPS Surprise Amid Quiet Revenue Disclosures BSRR Q1 2026 Earnings EPS Beats Estimates by 144 Shares Edge Higher Dianthus Therapeutics Q1 2026 Earnings BetterthanExpected Loss Despite No Revenue ATAT Q1 2026 Earnings EPS Surges Past Estimates Stock Declines Despite Strong Beat PZZA Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction